A Startup Has Unlocked a Way to Make Cheap Insulin
11 months, 1 week ago

A Startup Has Unlocked a Way to Make Cheap Insulin

Wired  

Around 8 million people in the United States rely on insulin to manage their diabetes, but steady price increases have made the life-saving medicine increasingly more difficult to afford. CEO Cameron Owen says his company has created novel strains of bacteria that can produce insulin at twice the yield than is currently possible. A 2020 estimate by the RAND Corporation put the average list price of a vial of insulin at $98 in the US compared with $12 in Canada and $7.52 in the UK. These companies set the list prices for insulin and work with intermediaries called pharmacy benefit managers, or PBMs, to get their products covered by health insurance plans.

Price Insulin  unlocked  rebates  price  rbio  way  plans  manufacturers  biosimilar  startup  list  insulin  cheap  products  prices

History of this topic

Frustrated with high drug costs, biohackers are reverse engineering medical treatments
1 month ago

Frustrated with high drug costs, biohackers are reverse engineering medical treatments

Salon  

The crescendo of outrage at the health care system lately has some arguably valid complaints. “Among diabetics, there is quite a lot of desperation, and there’s quite a lot of people facing really serious health consequences and often even death because of the fairly arbitrary and often deeply flawed ways that the system that provides us with the medicine we …

California, drugmaker partner to produce affordable insulin
1 year, 9 months ago

California, drugmaker partner to produce affordable insulin

Associated Press  

DOWNEY, Calif. — The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and push down prices for a medication used by millions of Americans. Newsom said a 10- milliliter vial of the state-branded insulin would sell for $30, but it’s possible competitors could …

California aims to slash insulin prices and challenge Big Pharma. Can it succeed?
2 years, 7 months ago

California aims to slash insulin prices and challenge Big Pharma. Can it succeed?

LA Times  

Diabetes patient Adam Winney of Van Nuys is seen with samples of fast-acting insulin that he received from his doctor in August of 2020. Newsom is asking state lawmakers to pump $100 million into an ambitious initiative to launch California’s generic drug label, CalRx, and begin producing insulin in the next few years, said Alex Stack, a Newsom spokesperson. He …

Rising Insulin Cost Leading to Non-Compliance in Diabetics, Cheaper Options May Improve Access: Study
2 years, 7 months ago

Rising Insulin Cost Leading to Non-Compliance in Diabetics, Cheaper Options May Improve Access: Study

News 18  

Rising cost of insulin has been resulting in non-compliance in patients with diabetes mellitus, finds an Indian study published in the journal Science Direct. While rising cost of insulin poses a challenge in controlling the disease, the study said the introduction of biosimilar insulin has enabled wider access of insulin with a reduced price of about 20%-40%. “The aim of …

Discover Related